184 related articles for article (PubMed ID: 20694413)
21. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.
Kienitz T; Quinkler M; Strasburger CJ; Ventz M
Eur J Endocrinol; 2007 Jul; 157(1):39-46. PubMed ID: 17609400
[TBL] [Abstract][Full Text] [Related]
22. [Thyrotropin--TSH secreting pituitary tumor].
Zieliński G; Podgórski JK; Warczyńska A; Koziarski A; Zgliczyński W
Przegl Lek; 2002; 59(12):1018-23. PubMed ID: 12731380
[TBL] [Abstract][Full Text] [Related]
23. Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two cases.
Tokutsu A; Okada Y; Torimoto K; Otsuka T; Narisawa M; Kurozumi A; Tanaka Y
Neuro Endocrinol Lett; 2020 Apr; 41(1):10-16. PubMed ID: 32338854
[TBL] [Abstract][Full Text] [Related]
24. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
[TBL] [Abstract][Full Text] [Related]
26. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
Iglesias P; Díez JJ
J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
[TBL] [Abstract][Full Text] [Related]
27. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
Fukuda T; Yokoyama N; Tamai M; Imaizumi M; Kimura H; Tominaga T; Ashizawa K; Kiriyama T; Yoshimine H; Ohishi K; Eguchi K
Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
[TBL] [Abstract][Full Text] [Related]
28. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
Macchia E; Gasperi M; Lombardi M; Morselli L; Pinchera A; Acerbi G; Rossi G; Martino E
J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
[TBL] [Abstract][Full Text] [Related]
29. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
30. [Thyrotropin-secreting pituitary adenomas].
Caron P
Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.
Han R; Shen L; Zhang J; Xie J; Fang W; Sun Q; Bian L; Zhou Y; Wang S; Ning G; Wang W; Ye L
Thyroid; 2020 Sep; 30(9):1236-1244. PubMed ID: 32212919
[No Abstract] [Full Text] [Related]
32. [Somatostatin analogs in the clinical management of pituitary neoplasms].
Colao A; Dorato M; Pulcrano M; Rossi FW; Auriemma RS; Lombardi G; Lastoria S
Minerva Endocrinol; 2001 Sep; 26(3):181-91. PubMed ID: 11753242
[TBL] [Abstract][Full Text] [Related]
33. Long-term primary medical therapy with somatostatin analogs in acromegaly.
Su DH; Liao KM; Chen HW; Chang TC
J Formos Med Assoc; 2006 Aug; 105(8):664-9. PubMed ID: 16935768
[TBL] [Abstract][Full Text] [Related]
34. Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.
Maiza JC; Vezzosi D; Matta M; Donadille F; Loubes-Lacroix F; Cournot M; Bennet A; Caron P
Clin Endocrinol (Oxf); 2007 Aug; 67(2):282-9. PubMed ID: 17524029
[TBL] [Abstract][Full Text] [Related]
35. [Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients].
Trukhina DA; Przhiyalkovskaya EG; Belaya ZE; Grigoriev AY; Azizyan VN; Mamedova EO; Rozhinskaya LY; Lapshina AM; Pigarova EA; Dzeranova LK; Platonova NM; Troshina EA; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):23-36. PubMed ID: 38796758
[TBL] [Abstract][Full Text] [Related]
36. Use of somatostatin analogue in management of a thyrotrophin secreting pituitary adenoma.
Stiles MK; Conaglen JV; Speed J; Chatterton B
Aust N Z J Med; 1996 Feb; 26(1):122-3. PubMed ID: 8775545
[No Abstract] [Full Text] [Related]
37. Ectopic pituitary adenoma of the TSH-secreting sphenoidal sinus with excellent response to somatostatin analogs. Theory of the embryogenesis and literature review from a clinical case.
Ortiz E; Peldoza M; Monnier E; Gejman R; Henriquez M; Barra MI; Gayoso R; Sapunar J; Villaseca M; Guzmán P
Steroids; 2020 Feb; 154():108535. PubMed ID: 31704334
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.
Gesundheit N; Petrick PA; Nissim M; Dahlberg PA; Doppman JL; Emerson CH; Braverman LE; Oldfield EH; Weintraub BD
Ann Intern Med; 1989 Nov; 111(10):827-35. PubMed ID: 2479309
[TBL] [Abstract][Full Text] [Related]
40. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
Socin HV; Chanson P; Delemer B; Tabarin A; Rohmer V; Mockel J; Stevenaert A; Beckers A
Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]